Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05345626
Other study ID # Rigshospitalet, Copenhagen
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 14, 2019
Est. completion date October 8, 2021

Study information

Verified date May 2022
Source Rigshospitalet, Denmark
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Some patients unable to return home from hospital due to physical or mental illness will be discharged to a rehabilitation home to restore strength and rehabilitate. This study attempts to examine if it is possible to continuously monitor the vital signs in patients discharged to a rehabilitation center and whether wearable devices will detect more abnormal vital signs than the rehabilitation facility, as well as complication and readmission rates.


Description:

Patients who are ready to leave the hospital but are deemed unable to return home are discharged to a rehabilitation center to regain strength and performance. Vital signs are only measured when deemed necessary at the rehabilitation center, in contrast to hospital wards, where vital signs are measured intermittently and manually every 8-12 hours. Wearable devices that continuously monitor a patient's vital signs may be able to detect patients who are deteriorating, as abnormal vital signs often precede a physiologic decline This study aims to determine whether it is possible to continuously monitor patients discharged to a rehabilitation center and detect more abnormal vital signs than measurements from the rehabilitation center. By attaching three wearable devices to 20 patients, we wished to record the vital signs for up to 96 hours, documenting abnormal vital signs as well as complications - and readmission rates.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date October 8, 2021
Est. primary completion date September 8, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 110 Years
Eligibility Inclusion Criteria: - discharged to the rehabilitation center after surgery or; diagnosed with ischemic heart disease, chronic heart disease, apoplexia cerebri, chronic obstructive pulmonary disease, or diabetes. - Inclusion less than 72 h from rehabilitation admission Exclusion Criteria: - Unable to give informed consent - Implanted pacemaker or cardioverter-defibrillator - allergic to plaster, plastic, silicone

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Denmark Center for Rehabilitering og Akutpleje - Bystævneparken Brønshøj

Sponsors (1)

Lead Sponsor Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Complication Complication frequency within 30 days from study inclusion 30 days
Other Readmission Readmission frequency within 30 days from study inclusion 30 days
Primary Monitoring time Monitoring time with data from any device 96 hours
Secondary SpO2 < 92% Duration of SpO2 < 92% 96 hours
Secondary SpO2 < 88% Duration of SpO2 < 88% 96 hours
Secondary SpO2 < 85% Duration of SpO2 < 85% 96 hours
Secondary SpO2 < 80% Duration of SpO2 < 80% 96 hours
Secondary Respiratory rate <5 breaths per minute Duration of respiratory rate <5 breaths per minute 96 hours
Secondary Respiratory rate <11 breaths per minute Duration of respiratory rate <11 breaths per minute 96 hours
Secondary Respiratory rate >24 breaths per minute Duration of respiratory rate >24 breaths per minute 96 hours
Secondary Respiratory rate >30 breaths per minute Duration of respiratory rate >30 breaths per minute 96 hours
Secondary Heart rate <30 beats per minute Duration of heart rate <30 beats per minute 96 hours
Secondary Heart rate <40 beats per minute Duration of heart rate <40 beats per minute 96 hours
Secondary Heart rate > 110 beats per minute Duration of heart rate > 110 beats per minute 96 hours
Secondary Heart rate > 130 beats per minute Duration of heart rate > 130 beats per minute 96 hours
Secondary Systolic blood pressure <70 mmHg Number of systolic blood pressure <70 mmHg measurements 96 hours
Secondary Systolic blood pressure <90 mmHg Number of systolic blood pressure <90 mmHg measurements 96 hours
Secondary Systolic blood pressure >180 mmHg Number of systolic blood pressure >180 mmHg measurements 96 hours
Secondary Systolic blood pressure >220 mmHg Number of systolic blood pressure >220 mmHg measurements 96 hours
See also
  Status Clinical Trial Phase
Completed NCT03434626 - Advance Care Planning & Goals of Care Randomized Controlled Trial in Primary Care N/A
Completed NCT04409197 - Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network
Recruiting NCT04748770 - Access to Kidney Transplant of Obese Patients Beginning Dialysis
Recruiting NCT02880059 - Incidence and Effects of Sleep Apnea on Intracerebral Aneurysms N/A
Active, not recruiting NCT04087239 - The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study
Completed NCT04109001 - Method of Measuring Comorbidity to Predict Outcome After Intensive Care
Completed NCT03348449 - Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)